Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

    Jayesh Dalpatbhai Solanki1★, Amit H. Makwana1, Hemant B. Mehta1, Pradnya A. Gokhale1, Chinmay J. Shah1★ Corresponding author

    1. 1Department of Physiology, Government Medical College, Bhavnagar, Gujarat, India.

    CORRESPONDENCE

    Jayesh Dalpatbhai Solanki

    Department of Physiology, Government Medical College, Bhavnagar, Gujarat, India.

    drjaymin_83@yahoo.com

    Received: 18-12-2015; Revised: 19-02-2016; Accepted: 21-05-2016.

    Volume 7, Issue 2 · pp. 87–92 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.184772

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objective: To correlate BMI, lipidemic control, and statin therapy with PAD measured by ABI in low risk type 2 diabetics. Materials and Methods: A sample of 101 nonsmoking, asymptomatic type 2 diabetics (50 males, 51 females) with known glycemic (fasting blood sugar, postprandial blood sugar, glycosylated hemoglobin) and lipidemic (total cholesterol, lipoproteins, and triglycerides [TGAs]) control was taken. Vascular Doppler was used to derive ABI and PAD was defined as ABI <0.9. ABI values were compared amongst groups and P < 0.05 was considered statistically significant. Results: We found fairly good lipid but poor glycemic control and prevalence of PAD 30%. There was insignificantly low ABI profile in patient having BMI ≥25, hyperlipidemia and absent statin therapy with odds ratio being highest for TGAs ≥150 (3.23) followed by BMI ≥25 (2.61), high‑density lipoprotein ≤50 (1.61), low‑density lipoprotein ≥100 (1.20), and disuse of statin (1.14) with significance only for BMI. Conclusion: We observed small, insignificant PAD risk by dyslipidemia or non‑use of statins in low‑risk ambulatory T2DM patients, not so by BMI. This suggests importance of good glycemic control, maintenance of optimum weight, and lifestyle modifications as primary prevention rather than opting for costly and inefficient secondary prevention.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Solanki, J. D., Makwana, A. H., Mehta, H. B., Gokhale, P. A., & Shah, C. J. (2016). Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?. Journal of Pharmacology and Pharmacotherapeutics, 7(2), 87–92. https://doi.org/10.4103/0976-500X.184772